All News

2060 articles, sorted by publication time.

Cell Therapy · uk

Putting the Brakes on the Immune Response: First Patients with Autoimmune Diseases Receive Engineered Regulatory T Cells

The first three patients in the CHILL trial have received QEL-005, and the study has advanced to the second dose cohort following a safety review. The therapy aims to calm uncontrolled immune responses using patients’ own regulatory T cells, but whether it can improve disease—and how long any benefit might last—remains to be answered by human data.

New Drugs and Clinical Research · global

RAS inhibitor extends survival in advanced pancreatic cancer; mRNA flu vaccine and oral dermatomyositis drug receive U.S. approval

In August 2026, the United States approved several new therapies in succession. Among them, daraxonrasib increased median overall survival to 13.2 months in patients with metastatic pancreatic cancer in a randomized trial. Each new option across these different diseases also comes with evidence limitations that require careful consideration.

New Drugs and Clinical Trials · global

Maintaining control of intraocular inflammation after steroid withdrawal: brepocitinib meets endpoints in two Phase 3 trials

In two uveitis trials, about 60% of patients receiving the drug achieved steroid-free disease quiescence at week 48, compared with about 20% in the placebo groups. The findings provide new evidence for reducing steroid dependence, but comparisons with existing treatments and long-term safety remain to be clarified.

Medical Artificial Intelligence · us

Distinguishing Precancerous Colorectal Lesions: Vision Transformer Improves Detection Sensitivity in Pathology Image Testing

A study using a public dataset found that a Vision Transformer achieved nearly 70% sensitivity in identifying sessile serrated adenomas, compared with about 40% for the convolutional model used for comparison. Whether this advantage can translate into support for clinical interpretation still requires validation across datasets and in prospective studies.